Tackling vascular risk factors as a possible disease modifying intervention in Parkinson’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Tackling vascular risk factors as a possible disease modifying intervention in Parkinson’s disease ; volume:10 ; number:1 ; day:2 ; month:3 ; year:2024 ; pages:1-4 ; date:12.2024
npj Parkinson's Disease ; 10, Heft 1 (2.3.2024), 1-4, 12.2024
- Creator
-
Visser, Anne E.
Vries, Nienke M. de
Richard, Edo
Bloem, Bastiaan R.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41531-024-00666-6
- URN
-
urn:nbn:de:101:1-2405071031134.242084780073
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Visser, Anne E.
- Vries, Nienke M. de
- Richard, Edo
- Bloem, Bastiaan R.
- SpringerLink (Online service)
Other Objects (12)
Parkinson’s Disease Risk and Hyperhomocysteinemia: The Possible Link
Fatigue in fluctuating Parkinson’s disease patients: possible impact of safinamide
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Pathological mechanisms of neuroimmune response and multitarget disease-modifying therapies of mesenchymal stem cells in Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
npj Parkinson's Disease
Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics
Dopamine modification of glycolytic enzymes impairs glycolysis: possible implications for Parkinson’s disease
Genetic Architecture of Parkinson’s Disease
Molecular pathways to Parkinson’s disease
Parkinson’s Disease Risk and Hyperhomocysteinemia: The Possible Link
Fatigue in fluctuating Parkinson’s disease patients: possible impact of safinamide
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Pathological mechanisms of neuroimmune response and multitarget disease-modifying therapies of mesenchymal stem cells in Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
npj Parkinson's Disease
Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics
Dopamine modification of glycolytic enzymes impairs glycolysis: possible implications for Parkinson’s disease
Genetic Architecture of Parkinson’s Disease
Molecular pathways to Parkinson’s disease
Parkinson’s Disease Risk and Hyperhomocysteinemia: The Possible Link
Fatigue in fluctuating Parkinson’s disease patients: possible impact of safinamide
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Pathological mechanisms of neuroimmune response and multitarget disease-modifying therapies of mesenchymal stem cells in Parkinson’s disease
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
npj Parkinson's Disease
Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics
Dopamine modification of glycolytic enzymes impairs glycolysis: possible implications for Parkinson’s disease
Genetic Architecture of Parkinson’s Disease